Myotonic dystrophy type 2

被引:34
作者
Finsterer, J [1 ]
机构
[1] Neurol Krankenhaus Rosenhugel, Vienna, Austria
关键词
multisystem disease; muscular dystrophy; myopathy; myotonia; neuromuscular disorder;
D O I
10.1046/j.1468-1331.2002.00453.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myotonic dystrophy type 2 (DM2) is a clinically but not genetically heterogeneous, multisystem disorder, that is clinically similar to, but distinct from myotonic dystrophy type 1 (DM1). Initially, different phenotypes of DM2 were described by Ricker (proximal myotonic myopathy, PROMM), Ranum (myotonic dystrophy 2, DM2) and Udd (proximal myotonic dystrophy, PDM). Clinical features these three phenotypes had in common were diffuse, proximal or distal weakness, wasting, myotonia, cataract, cerebral, endocrine and cardiac abnormalities. Initially, the clinical differences between DM1 and PROMM seemed unmistakable, but meanwhile it has become apparent that the clinical differences between these entities are blurring. In 1999, Day et al., Meola et al. and Ricker et al. mapped the mutated gene of all three phenotypes, to chromosome 3q. In 2001, the three different phenotypes were found to rely on the same mutation in the ZNF9 gene on chromosome 3q21.3. Although DM2. may be clinically heterogeneous, it is by result of a mutation in a single gene. The mutation responsible for DM2 is a CCTG-repeat expansion of 75-11000 repeats in intron 1 of the ZNF9 gene on chromosome 3q21.3. Because of the clinical heterogeneity, the diagnosis of DM2 should rely on DNA analysis alone.
引用
收藏
页码:441 / 447
页数:7
相关论文
共 49 条
[11]   Myotonic dystrophy: molecular windows on a complex etiology [J].
Korade-Mirnics, Z ;
Babitzke, P ;
Hoffman, E .
NUCLEIC ACIDS RESEARCH, 1998, 26 (06) :1363-1368
[12]   Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9 [J].
Liquori, CL ;
Ricker, K ;
Moseley, ML ;
Jacobsen, JF ;
Kress, W ;
Naylor, SL ;
Day, JW ;
Ranum, LPW .
SCIENCE, 2001, 293 (5531) :864-867
[13]   Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy [J].
Lu, XH ;
Timchenko, NA ;
Timchenko, LT .
HUMAN MOLECULAR GENETICS, 1999, 8 (01) :53-60
[14]   Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat [J].
Mankodi, A ;
Logigian, E ;
Callahan, L ;
McClain, C ;
White, R ;
Henderson, D ;
Krym, M ;
Thornton, CA .
SCIENCE, 2000, 289 (5485) :1769-1772
[15]   Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2 [J].
Mankodi, A ;
Urbinati, CR ;
Yuan, QP ;
Moxley, RT ;
Sansone, V ;
Krym, M ;
Henderson, D ;
Schalling, M ;
Swanson, MS ;
Thornton, CA .
HUMAN MOLECULAR GENETICS, 2001, 10 (19) :2165-2170
[16]   Dominantly inherited proximal myotonic myopathy and leukoencephalopathy in a family with an incidental CLCN1 mutation [J].
Mastaglia, FL ;
Harker, N ;
Phillips, BA ;
Day, TJ ;
Hankey, GJ ;
Laing, NG ;
Fabian, V ;
Kakulas, BA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (04) :543-547
[17]   Myotonic dystrophies - how many are there? [J].
Mastaglia, FL .
CURRENT OPINION IN NEUROLOGY, 1999, 12 (05) :491-492
[18]   Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy [J].
Meola, G ;
Sansone, V ;
Perani, D ;
Colleluori, A ;
Cappa, S ;
Cotelli, M ;
Fazio, F ;
Thornton, CA ;
Moxley, RT .
NEUROLOGY, 1999, 53 (05) :1042-1050
[19]  
Meola G, 2000, MUSCLE NERVE, V23, P1789, DOI 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO
[20]  
2-4